Redi.Health’s Post

Germans, historically, have had strong, long-standing relationships with their general practitioners, or Hausarzt. But recent events have disrupted these relationships. ZS’s William (Bill) Coyle, Eva Struckmeyer and Kevin Santo, who serve clients in the EU, explain how partnerships with pharma can help providers make their patients feel more cared for. https://bit.ly/3JkJNRY #futureofhealth #patientcentricity

No better way to wrap up my first week leading the Pain Interventions organization than receiving word that our Inceptiv spinal cord stimulator has earned regulatory approval in Western Europe. Inceptiv will be a game-changer for patients in Europe, capable of sensing the body’s neural response to stimulation 50 times per second. In a clinical study (ECHO-MAC), 9 out of 10 patients preferred the optional closed-loop setting compared to fixed-output stimulation. The future is bright, and I’m so grateful to be a part of the Medtronic Pain Interventions team. We look forward to bringing Inceptiv™ to people in Europe who are suffering from chronic pain. Note: Inceptiv™ is not approved for sale in the United States. See risk information: https://bit.ly/3OuzyxQ #MedtronicEmployee; #ChronicPain; #PainManagement

[Singapore, July 16, 2024] – GO-Dx Corporation Ltd (Aust) (Ticker: GD8), a forefront innovator in diagnostic and health profiling technologies, today proudly announces the commencement of trading of its shares on the National Stock Exchange (NSX). Founded with a mission to revolutionize diagnostic and precision medicine solutions, GO-Dx has swiftly emerged as a pivotal player in the healthcare technology sector. The NSX listing marks a significant milestone in the company’s trajectory, enhancing visibility and expanding accessibility to a broader investor community. Dr Lim Kah Meng, CEO of GO-Dx Corporation (Aust) Ltd, commented, “We are thrilled to embark on this new phase of growth and development as a publicly listed entity on the NSX. This milestone will empower us to fortify our market position, accelerate innovation, and drive sustained value creation for our shareholders.” The listing underscores GO-Dx’s unwavering commitment to transparency, accountability, and shareholder value. The company remains steadfast in advancing its mission to deliver state-of-the-art diagnostic and precision medicine solutions that elevate patient outcomes on a global scale. About GO-Dx Corporation Ltd (Aust) GO-Dx Corporation (Aust) Ltd is a pioneering healthcare technology company specializing in advanced diagnostic and precision medicine solutions. With a focus on innovation and customer-centricity, GO-Dx is dedicated to enhancing diagnostic and health profiling accuracy and efficiency across diverse healthcare settings. For detailed listing information, please visit https://lnkd.in/eB2XqXuA

Come learn more about what KPH has to offer! 💙🧡💙🧡

🌟 Pivotal Scientific Links Event: A Success for PanPath B.V. 🌟 We are thrilled to share our experience from the Pivotal Scientific Links event, held on the 17th and 18th of June. Representing PanPath B.V., our team had the opportunity to engage with a dynamic community of industry professionals, potential distributors, clients, and business partners. The event was a significant milestone for us, filled with fruitful discussions and promising new connections. Key highlights include: 🤝 Connecting with Potential Distributors: We met with several potential distributors who share our vision and commitment to advancing diagnostic solutions. These new relationships are crucial for expanding our global presence and making a meaningful impact on patient care. 📈 Engaging with Prospective Clients: We had the opportunity to showcase our innovative solutions to potential clients. The positive feedback and keen interest we received reaffirm our dedication to precision medicine and its transformative potential. 💬 Strengthening Existing Partnerships: Reconnecting with our existing partners and exploring new avenues for collaboration was a highlight of the event. Strengthening these relationships is essential for mutual growth and success. Events like Pivotal Scientific Links are vital for fostering collaboration and driving innovation in the diagnostic industry. We are excited about the opportunities ahead and look forward to leveraging the connections made to enhance our offerings and reach. A heartfelt thank you to the organizers for hosting such a well-organized and impactful event Pivotal Scientific Limited. Together, we are making strides towards a future where advanced diagnostics significantly improve patient outcomes globally. #PivotalScientificLinks #Networking #BusinessDevelopment #PanPath #Diagnostics #PrecisionMedicine #HealthcareInnovation #GlobalReach

Ever wondered about the David and Goliath duel in the pharmacy world? Big Pharma, like Goliath, has the power, the resources, and the influence. They are the movers and shakers of the healthcare industry, dictating trends and defining norms. Meanwhile, Small Pharmacies, much like David, are in the shadows. They're small, local, community-oriented. Their power isn't in their size, but in their relationships, their trust, their commitment to personal care. But here's a twist. Small Pharmacies are not just surviving, they're thriving. They're leveraging their unique strengths - personalized services, community trust, and quick adaptability. They're not trying to match Big Pharma's scale but are capitalizing on their nimbleness and customer-centric approach. In this battle, size isn't everything. The slingshot in Small Pharmacies' hand is their ability to innovate, to adapt, to pivot faster than their massive counterparts. They are proving that personalized care can hold its own against mass production. So, the next time you think of 'Pharmacy', don't just think 'Big Pharma'. Think 'Small Pharmacies', the resilient David in a world of Goliaths. Let's start recognizing the value in the small, the local, the personal. Engage with this post if you believe in the power of small pharmacies. Let's amplify their voices in this mighty battle.

Our recent symposium in Little Rock on the future of health care in Arkansas featured a panel discussion with Stuart M. Irby, Jr. of Stephens, Dr. Kevin W. Sexton of BioVentures, LLC, Richard L. Moss, PhD of University of Arkansas - Pulaski Technical College, and Dr. Harold Betton of the Arkansas Medical Dental Pharmaceutical Association. Read four takeaways on our blog. #telehealth #AI #ACHI25

T-1 week! Kick off your week on the right foot by dialing into this dynamic #SMMGMedTech session between Amy and Thomas on how data, AI, and RepSignal are revolutionizing medtech sales. Don't forget to sign up as an SMMG member to expand your network of medtech commercial thought leaders and gain unique strategies on how to advance your team and your career.

As a growing number of innovative CGTs progress to clinical trial stages, we enter a new era of better patient outcomes. The CRO’s responsibility for managing and conducting these first-in-human studies is pivotal, with success, in part relying on their handling of the uniquely complex logistical needs of CGTs. In this new white paper, we explore the synergies of CROs and specialty logistics companies required for clinical trial success and healthier patient futures. One strategic partnership unpacked is between World Courier and IQVIA. Our networks overlap, thus enabling a greater ability to recruit patients, mitigate risk, and reduce transit times associated with CGT assets. Learn more now: https://lnkd.in/eEnCp6SG